Polymer nanocarriers protecting active enzyme cargo against proteolysis

被引:78
作者
Dziubla, TD
Karim, A
Muzykantov, VR
机构
[1] Univ Penn, Sch Med, Inst Environm Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
antioxidant delivery; protein loading; catalase; nanoparticle; biodegradable;
D O I
10.1016/j.jconrel.2004.10.017
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Polymeric nanocarriers (PNCs), proposed as an attractive vehicle for vascular drug delivery, remain an orphan technology for enzyme therapies due to poor loading and inactivation of protein cargoes. To unite enzyme delivery by PNC with a clinically relevant goal of containment of vascular oxidative stress, a novel freeze-thaw encapsulation strategy was designed and provides similar to20% efficiency loading of an active large antioxidant enzyme, catalase, into PNC (200-300 nm) composed of biodegradable block copolymers poly(ethylene glycol)-b-poly(lactic-glycolic acid). Catalase's substrate, H2O2, was freely diffusible in the PNC polymer. Furthermore, PNC-loaded catalase stably retained 25-30% Of H2O2-degrading activity for at least 18 h in a proteolytic environment, while free catalase lost activity within 1 h. Delivery and protection of catalase from lysosomal degradation afforded by PNC nanotechnology may advance effectiveness and duration of treatment of diverse disease conditions associated with vascular oxidative stress. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:427 / 439
页数:13
相关论文
共 43 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]  
Arica MY, 1999, POLYM INT, V48, P879
[3]   Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress [J].
Atochina, EN ;
Balyasnikova, IV ;
Danilov, SM ;
Granger, DN ;
Fisher, AB ;
Muzykantov, VR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1998, 275 (04) :L806-L817
[4]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[5]   Water, solute and protein diffusion in physiologically responsive hydrogels of poly(methacrylic acid-g-ethylene glycol) [J].
Bell, CL ;
Peppas, NA .
BIOMATERIALS, 1996, 17 (12) :1203-1218
[6]   PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress [J].
Christofidou-Solomidou, M ;
Scherpereel, A ;
Wiewrodt, R ;
Ng, K ;
Sweitzer, T ;
Arguiri, E ;
Shuvaev, V ;
Solomides, CC ;
Albelda, SM ;
Muzykantov, VR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 285 (02) :L283-L292
[7]   Chitosan nanoparticles:: a new vehicle for the improvement of the delivery of drugs to the ocular surface.: Application to cyclosporin A [J].
De Campos, AM ;
Sánchez, A ;
Alonso, MJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 224 (1-2) :159-168
[8]   Attenuation of rat lung isograft reperfusion injury with a combination of anti-ICAM-1 and anti-beta 2 integrin monoclonal antibodies [J].
DeMeester, SR ;
Molinari, MA ;
Shiraishi, T ;
Okabayashi, K ;
Manchester, JK ;
Wick, MR ;
Cooper, JD ;
Patterson, GA .
TRANSPLANTATION, 1996, 62 (10) :1477-1485
[9]  
Gaspar MM, 1998, J CONTROL RELEASE, V52, P53
[10]   PULMONARY STRATEGIES OF ANTIOXIDANT DEFENSE [J].
HEFFNER, JE ;
REPINE, JE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :531-554